An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
Back to Lifestyle
Lifestyle
September 23, 2026 at 9:47 PM
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
STAT News
Excerpt from STAT News.